Literature DB >> 9869557

Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.

A Pascual1, I García, S Ballesta, E J Perea.   

Abstract

The penetration by moxifloxacin of human neutrophils (polymorphonuclear leukocytes [PMN]) and tissue-cultured epithelial cells (McCoy cells) was evaluated by a fluorometric assay. At extracellular concentrations of 5 mg/liter, the cellular-to-extracellular concentration ratios (C/E) of moxifloxacin in PMN and McCoy cells were 10.9 +/- 1.0 and 8.7 +/- 1.0, respectively (20 min; 37 degrees C). The uptake of moxifloxacin by PMN was rapid, reversible, nonsaturable (at extracellular concentrations ranging from 1 to 50 microg/ml), and not affected by cell viability. The uptake of moxifloxacin was affected by external pH and the environmental temperature. The incubation of PMN in the presence of sodium fluoride, sodium cyanide, and carbonyl cyanide m-chlorophenylhydrazone significantly decreased the C/E of this agent. Neither PMN stimulation nor phagocytosis of opsonized Staphylococcus aureus significantly affected the uptake of moxifloxacin by human PMN. This agent, at concentrations of 0.5, 1, and 5 mg/liter, induced a significant reduction in the survival of intracellular S. aureus in human PMN. In summary, moxifloxacin reaches much higher intracellular concentrations within phagocytic and nonphagocytic cells than extracellular ones, remaining active inside the neutrophils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869557      PMCID: PMC89012     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes.

Authors:  A Pascual; I Garcia; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.

Authors:  P K Peterson; J Verhoef; D Schmeling; P G Quie
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

3.  Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis.

Authors:  B P Buggy; D R Schaberg; R D Swartz
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

4.  Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells.

Authors:  I García; A Pascual; M C Guzman; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

5.  Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells.

Authors:  A Pascual; I Garcia; E J Perea
Journal:  Diagn Microbiol Infect Dis       Date:  1992-07       Impact factor: 2.803

6.  Clindamycin uptake by human neutrophils.

Authors:  M S Klempner; B Styrt
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

7.  Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes.

Authors:  I García; A Pascual; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

8.  Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells.

Authors:  A Pascual; I Garcia; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

9.  Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes.

Authors:  A Pascual; D Tsukayama; J Kovarik; G Gekker; P Peterson
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

10.  Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.

Authors:  N Mor; J Vanderkolk; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more
  22 in total

1.  Activities of antimicrobial agents against intracellular pneumococci.

Authors:  G L Mandell; E J Coleman
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.

Authors:  Q Yang; R J Nakkula; J D Walters
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

3.  Intracellular penetration and activity of DX-619 in human polymorphonuclear leukocytes.

Authors:  Isabel García; Sofía Ballesta; Concepción Murillo; Evelio J Perea; Alvaro Pascual
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.

Authors:  Florian Islinger; Rene Bouw; Mathias Stahl; Edith Lackner; Petra Zeleny; Martin Brunner; Markus Müller; Hans Georg Eichler; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.

Authors:  Jolanta Majcher-Peszynska; Marko Sass; Sora Schipper; Viktor Czaika; Andreas Gussmann; Ralf Lobmann; Ralf G Mundkowski; Christoph Luebbert; Peter Kujath; Bernhard R Ruf; Horst Koch; Wolfgang Schareck; Ernst Klar; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2010-09-25       Impact factor: 2.953

6.  Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.

Authors:  Andrea N Edginton; Gertrud Ahr; Stefan Willmann; Heino Stass
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

7.  Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge.

Authors:  Martina Ulrich; Cordula Albers; Jan-Georg Möller; Axel Dalhoff; Gisela Korfmann; Frank Künkele; Gerd Döring
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

8.  An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.

Authors:  James J Brayton; Qing Yang; Robin J Nakkula; John D Walters
Journal:  J Periodontol       Date:  2002-11       Impact factor: 6.993

9.  Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.

Authors:  Devyani Deshpande; Shashikant Srivastava; Claudia Meek; Richard Leff; Gerri S Hall; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

10.  Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

Authors:  Christina Kratzer; Wolfgang Graninger; Karin Macfelda; Astrid Buxbaum; Apostolos Georgopoulos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.